Carl Philpott1, Sally Erskine1, Claire Hopkins2, Emma Coombes1, Naveed Kara3, Vishnu Sunkareneni4, Shahram Anari5, Mahmoud Salam6, Amir Farboud7, Allan Clark. 1. Norwich Medical School, University of East Anglia, Norwich, UK. 2. ENT Department, Guys and St Thomas NHS Foundation Trust, London, UK. 3. ENT Department, Darlington Memorial Hospitals NHS Foundation Trust, Darlington, UK. 4. ENT Department, Royal Surrey County Hospital, Surrey, UK. 5. ENT Department, Heart of England NHS Foundation Trust, Birmingham, UK. 6. ENT Department, Ipswich Hospital NHS Trust, Ipswich, UK. 7. ENT Department, Betsi Cadwaladr University Health Board Wrexham Maelor Hospital, Wrexham, UK.
Abstract
BACKGROUND: Chronic rhinosinusitis (CRS) is a common and debilitating disorder. Little is known about the epidemiology of this disease. The aims of the study were to identify differences in socio-economic variables and quality of life between patients with chronic rhinosinusitis and healthy controls, to identify any significant associations between CRS and other medical co-morbidities, psychiatric disease or environmental exposure and to explore the experience of CRS from the perspective of CRS sufferers. METHODS: Participants were recruited from ENT clinics from 30 centres across the UK. They completed a study-specific questionnaire considering environmental, medical and socio-economic factors, and SF-36 and SNOT-22 scores. All participants with CRS were diagnosed by a clinician and categorised as having CRS (with polyposis, without polyposis or allergic fungal rhinosinusitis (AFRS)). Controls included family and friends of those attending ENT outpatient clinics and hospital staff who had no diagnosis of nose or sinus problems and had not been admitted to hospital in the previous 12 months. RESULTS: A total of 1470 study participants (1249 patients and 221 controls) were included in the final analysis. Highly significant differences were seen in generic and disease-specific quality of life scores between CRS sufferers and controls; mean SNOT-22 score 45.0 for CRS compared with 12.1 amongst controls. There were no clear differences in socioeconomic variables including social class, index of multiple deprivation and educational attainment between cases and controls. Common comorbidities with a clear association included respiratory and psychiatric disorders, with a higher frequency of reported upper respiratory tract infections. CONCLUSIONS: CRS is associated with significant impairment in quality of life and with certain medical co-morbidities. In contrast to other common ENT disorders, no socioeconomic differences were found between patients and controls in this study.
BACKGROUND:Chronic rhinosinusitis (CRS) is a common and debilitating disorder. Little is known about the epidemiology of this disease. The aims of the study were to identify differences in socio-economic variables and quality of life between patients with chronic rhinosinusitis and healthy controls, to identify any significant associations between CRS and other medical co-morbidities, psychiatric disease or environmental exposure and to explore the experience of CRS from the perspective of CRS sufferers. METHODS:Participants were recruited from ENT clinics from 30 centres across the UK. They completed a study-specific questionnaire considering environmental, medical and socio-economic factors, and SF-36 and SNOT-22 scores. All participants with CRS were diagnosed by a clinician and categorised as having CRS (with polyposis, without polyposis or allergic fungal rhinosinusitis (AFRS)). Controls included family and friends of those attending ENT outpatient clinics and hospital staff who had no diagnosis of nose or sinus problems and had not been admitted to hospital in the previous 12 months. RESULTS: A total of 1470 study participants (1249 patients and 221 controls) were included in the final analysis. Highly significant differences were seen in generic and disease-specific quality of life scores between CRS sufferers and controls; mean SNOT-22 score 45.0 for CRS compared with 12.1 amongst controls. There were no clear differences in socioeconomic variables including social class, index of multiple deprivation and educational attainment between cases and controls. Common comorbidities with a clear association included respiratory and psychiatric disorders, with a higher frequency of reported upper respiratory tract infections. CONCLUSIONS:CRS is associated with significant impairment in quality of life and with certain medical co-morbidities. In contrast to other common ENT disorders, no socioeconomic differences were found between patients and controls in this study.
Authors: A G Hirsch; W F Stewart; A S Sundaresan; A J Young; T L Kennedy; J Scott Greene; W Feng; B K Tan; R P Schleimer; R C Kern; A Lidder; B S Schwartz Journal: Allergy Date: 2016-09-19 Impact factor: 13.146
Authors: Daniel M Beswick; Jess C Mace; Zachary M Soler; Luke Rudmik; Jeremiah A Alt; Kristine A Smith; Kara Y Detwiller; Vijay R Ramakrishnan; Timothy L Smith Journal: Int Forum Allergy Rhinol Date: 2019-06-27 Impact factor: 3.858
Authors: Carl M Philpott; Sally Erskine; Claire Hopkins; Nirmal Kumar; Shahram Anari; Naveed Kara; Sankalp Sunkaraneni; Jaydip Ray; Allan Clark; Andrew Wilson; Sally Erskine; Carl Philpott; Allan Clark; Claire Hopkins; Alasdair Robertson; Shahzada Ahmed; Naveed Kara; Sean Carrie; Vishnu Sunkaraneni; Jaydip Ray; Shahram Anari; Paul Jervis; Jaan Panesaar; Amir Farboud; Nirmal Kumar; Russell Cathcart; Robert Almeyda; Hisham Khalil; Peter Prinsley; Nicolas Mansell; Mahmoud Salam; Jonathan Hobson; Jane Woods; Emma Coombes Journal: Respir Res Date: 2018-06-27
Authors: Maria Lauriello; Vittoria Di Rubbo; Gaia Sinatti; Marina Pasqua; Cinzia Tucci; Gian-Piero di Marco; Stefano Necozione; Alberto Eibenstein Journal: Allergy Rhinol (Providence) Date: 2019-08-01